Bressi Jerome Charles — SEC Form 4 filings
SEC reporting owner CIK 2034505. 2 Form 4 filings on record with FilingPulse; latest filed 2025-01-16.
Transaction summary — filings shown
Covers all 2 filings on record, filed 2025-01-13 to 2025-01-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 5,980 shares, $9,269 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
- Largest priced transaction: sale of 5,980 shares @ $1.55 ($9,269) in FATE THERAPEUTICS INC, filed 2025-01-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| FATE THERAPEUTICS INC (FATE) | See Remarks | 2 | — | 1 leg · 5,980 sh · $9,269 | 2 |
Form 4 filings — Bressi Jerome Charles
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-01-16 | 4 | FATE THERAPEUTICS INC (FATE) | Grant/award (A): 65,000 @ $0 · Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2025-01-13 | 4 | FATE THERAPEUTICS INC (FATE) | Sale (S): 5,980 @ $1.55 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2034505 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →